Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula

References

• 1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, et al. 2015. A global reference for human genetic variation. Nature 526:68–74.
   PubMed Web of Science ®Google Scholar
• Beoris M, Amos Wilson J, Garces JA, Lukowiak AA. 2016. CYP2D6 copy number distribution in the US population. Pharmacogenet Genomics 26:96–99.
   PubMed Web of Science ®Google Scholar
• Boattini A, Martinez-Cruz B, Sarno S, Harmant C, Useli A, Sanz P, Yang-Yao D, et al. 2013. Uniparental markers in Italy reveal a sex-biased genetic structure and different historical strata. PLoS One 8:e65441.
   PubMed Web of Science ®Google Scholar
• Caccamo D, Cesareo E, Mariani S, Raskovic D, Ientile R, Currò M, Korkina L, De Luca C. 2013. Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population. Oxid Med Cell Longev 2013:831969.
   PubMed Web of Science ®Google Scholar
• Capocasa M, Anagnostou P, Bachis V, Battaggia C, Bertoncini S, Biondi G, Boattini A, et al. 2014. Linguistic, geographic and genetic isolation: a collaborative study of Italian populations. J Anthropol Sci 92:201–231.
   PubMed Web of Science ®Google Scholar
• Chan SL, Jin S, Loh M, Brunham LR. 2015. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity. Pharmacogenomics 16:1161–1178.
   PubMed Web of Science ®Google Scholar
• De Fanti S, Sazzini M, Giuliani C, Frazzoni F, Sarno S, Boattini A, Marasco E, et al. 2015. Inferring the genetic history of lactase persistence along the Italian peninsula from a large genomic interval surrounding the LCT gene. Am J Phys Anthropol 158:708–718.
   PubMed Web of Science ®Google Scholar
• De Luca C, Scordo MG, Cesareo E, Pastore S, Mariani S, Maiani G, Stancato A, et al. 2010. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicol Appl Pharmacol 248:285–292.
   PubMed Web of Science ®Google Scholar
• Excoffier L, Lischer HE. 2010. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10:564–567.
   PubMed Web of Science ®Google Scholar
• Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS. 2016. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med 19:69–76.
   PubMed Web of Science ®Google Scholar
• Hicks JK, Swen JJ, Gaedigk A. 2014. Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization. Curr Drug Metab 15:218–232.
   PubMed Web of Science ®Google Scholar
• Hoffman SM, Nelson DR, Keeney DS. 2001. Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics 11:687–698.
   PubMedGoogle Scholar
• Hofmann MH, Blievernicht JK, Klein K, Saussele T, Schaeffeler E, Schwab M, Zanger UM. 2008. Aberrant splicing caused by single nucleotide polymorphism c.516G > T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver. J Pharmacol Exp Ther 325:284–292.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. 2007. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526.
   PubMed Web of Science ®Google Scholar
• Jacob RM, Johnstone EC, Neville MJ, Walton RT. 2004. Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping. Clin Chem 50:1372–1377.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Klein C, Meineke I, Sasse J, Zanger UM, Mürdter TE, Roots I, Brockmöller J. 2003. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6. Pharmacogenetics 13:619–626.
   PubMedGoogle Scholar
• Lang T, Klein K, Fischer J, Nüssler AK, Neuhaus P, Hofmann U, Eichelbaum M, et al. 2001. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 11:643.
   Google Scholar
• Myrand SP, Sekiguchi K, Man MZ, Lin X, Tzeng RY, Teng CH, Hee B, et al. 2008. Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. Clin Pharmacol Ther 84:347–361.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Wikvall K, Miller WL. 2013. Human cytochromes P450 in health and disease. Philos Trans R Soc Lond, B, Biol Sci 368:20120431.
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. 2004. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1–18.
   PubMedGoogle Scholar
• Persson A, Ingelman-Sundberg M. 2014. Pharmacogenomics of cytochrome P450 dependent metabolism of endogenous compounds: implications for behavior, psychopathology and treatment. J Pharmacogenomics Pharmacoproteomics 5:127.
   Google Scholar
• Radloff R, Gras A, Zanger UM, Masquelier C, Arumugam K, Karasi JC, Arendt V, et al. 2013. Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction tools. HumMutat 34:725–734.
   Google Scholar
• Riccardi LN, Carano F, Bini C, Ceccardi S, Ferri G, Pelotti S. 2015. CYP2B6 gene single-nucleotide polymorphisms in an italian population sample and relationship with nicotine dependence. Genet Test Mol Biomarkers 19:103–107.
   PubMed Web of Science ®Google Scholar
• Riccardi LN, Lanzellotto R, Falconi M, Ceccardi S, Bini C, Pelotti S. 2014. Development of a tetraplex PCR assay for CYP2D6 genotyping in degraded DNA samples. J Forensic Sci 59:690–695.
   PubMed Web of Science ®Google Scholar
• Riccardi LN, Lanzellotto R, Luiselli D, Ceccardi S, Falconi M, Bini C, Pelotti S. 2011. CYP2D6 genotyping in natives and immigrants from the Emilia-Romagna Region (Italy). Genet Test Mol Biomarkers 15:801–806.
   PubMed Web of Science ®Google Scholar
• Sazzini M, Gnecchi Ruscone GA, Giuliani C, Sarno S, Quagliariello A, De Fanti S, Boattini A, et al. 2016. Complex interplay between neutral and adaptive evolution shaped differential genomic background and disease susceptibility along the Italian peninsula. Sci Rep 6:32513.
   PubMed Web of Science ®Google Scholar
• Scordo MG, Aklillu E, Yasar U, Dahl ML, Spina E, Ingelman-Sundberg M. 2001. Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population. Br J Clin Pharmacol 52:447–450.
   PubMed Web of Science ®Google Scholar
• Scordo MG, Caputi AP, D'Arrigo C, Fava G, Spina E. 2004. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmacol Res 50:195–200.
   PubMed Web of Science ®Google Scholar
• Scott SA, Sangkuhl K, Stein CM, Hulot JS, Mega JL, Roden DM, Klein TE, Clinical Pharmacogenetics Implementation Consortium, et al. 2013. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther 94:317–323.
   PubMed Web of Science ®Google Scholar
• Serrano D, Lazzeroni M, Zambon CF, Macis D, Maisonneuve P, Johansson H, Guerrieri-Gonzaga A, et al. 2011. Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial. Pharmacogenomics J 11:100–107.
   PubMed Web of Science ®Google Scholar
• Shah RR, Gaedigk A, LLerena A, Eichelbaum M, Stingl J, Smith RL. 2016. CYP450 genotype and pharmacogenetic association studies: a critical appraisal. Pharmacogenomics 17:259–275.
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423.
   PubMed Web of Science ®Google Scholar
• Sistonen J, Fuselli S, Levo A, Sajantila A. 2005. CYP2D6 genotyping by a multiplex primer extension reaction. Clin Chem 51:1291–1295.
   PubMed Web of Science ®Google Scholar
• Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A. 2009. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics 19:170–179.
   PubMed Web of Science ®Google Scholar
• Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. 2007. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics 17:93–101.
   PubMed Web of Science ®Google Scholar
• Stephens M, Donnelly P. 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169.
   PubMed Web of Science ®Google Scholar
• Winner J, Allen JD, Altar CA, Spahic-Mihajlovic A. 2013. Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression. Transl Psychiatry 3:e242.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Turpeinen M, Klein K, Schwab M. 2008. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem 392:1093–1108.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Zhou ZW, Huang M. 2010. Polymorphisms of human cytochrome P450 2C9 and the functional relevance. Toxicology 278:165–188.
   PubMed Web of Science ®Google Scholar
• Zukunft J, Lang T, Richter T, Hirsch-Ernst KI, Nussler AK, Klein K, Schwab M, et al. 2005. A natural CYP2B6 TATA box polymorphism (-82T -> C) leading to enhanced transcription and relocation of the transcriptional start site. Mol Pharmacol 67:1772–1782.
   PubMed Web of Science ®Google Scholar